Cargando…
Characterization of Class-3 Semaphorin Receptors, Neuropilins and Plexins, as Therapeutic Targets in a Pan-Cancer Study
Class-3 semaphorins (SEMA3s), initially characterized as axon guidance cues, have been recognized as key regulators for immune responses, angiogenesis, tumorigenesis and drug responses. The functions of SEMA3s are attributed to the activation of downstream signaling cascades mainly mediated by cell...
Autores principales: | Zhang, Xiaoli, Shao, Shuai, Li, Lang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409005/ https://www.ncbi.nlm.nih.gov/pubmed/32640719 http://dx.doi.org/10.3390/cancers12071816 |
Ejemplares similares
-
Current drug design to target the Semaphorin/Neuropilin/Plexin complexes
por: Meyer, Lionel A. T., et al.
Publicado: (2016) -
Interactions between semaphorins and plexin–neuropilin receptor complexes in the membranes of live cells
por: Christie, Shaun M., et al.
Publicado: (2021) -
A pan-cancer study of class-3 semaphorins as therapeutic targets in cancer
por: Zhang, Xiaoli, et al.
Publicado: (2020) -
Neuropilins lock secreted semaphorins onto plexins in a ternary signaling complex
por: Janssen, Bert J.C., et al.
Publicado: (2012) -
Semaphorin-3C signals through Neuropilin-1 and PlexinD1 receptors to inhibit pathological angiogenesis
por: Yang, Wan-Jen, et al.
Publicado: (2015)